Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by De Geest, S.
Right arrow Articles by Moons, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Geest, S.
Right arrow Articles by Moons, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 457-459
© 2000 European Renal Association-European Dialysis and Transplant Association

Editorial Comments

The patient's appraisal of side-effects: the blind spot in quality-of-life assessments in transplant recipients

Sabina De Geest and Philip Moons

Centre for Health Services and Nursing Research, School of Public Health, Catholic University of Leuven, Leuven, Belgium

Correspondence and offprint requests to: Sabina De Geest PhD, RN,NFESC, Centre for Health Services and Nursing Research, School of Public Health, Catholic University of Leuven, Kapucijnenvoer 35, B-3000 Leuven, Belgium.

Introduction

Quality of life has emerged as an important outcome measure in health care over the past two decades and is increasingly used to evaluate treatment options. Indeed, understanding the quality-of-life implications of a new treatment modality in addition to studying its effects in terms of incidence of complications and mortality rate provides a more sophisticated and balanced view of treatment effects. Quality-of-life data offer a more complete understanding of the benefit/burden ratio associated with medical treatments in view of patients' physical, emotional/mental and social functioning. Furthermore, it provides a significant contribution to the allocation of health care resources, in determining reimbursement policies, and in individual medical decision processes [1,2].

Although quality of life has been extensively studied in transplant patients, a systematic assessment of symptoms and of side-effects related to immunosuppressive drugs is rarely integrated into quality-of-life research. However, the . . . [Full Text of this Article]

Definition of quality of life

Patients' appraisal of side-effects in quality-of-life assessments in transplant recipients

Conceptualization of transplant patients' symptom experience
Relevance of symptom experience for transplant research and clinical management
Measurement of symptom experience
Conclusion

Acknowledgments

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch Intern MedHome page
W. Rief, J. Avorn, and A. J. Barsky
Medication-Attributed Adverse Effects in Placebo Groups: Implications for Assessment of Adverse Effects
Arch Intern Med, January 23, 2006; 166(2): 155 - 160.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
K. Griva, J. P. Ziegelmann, D. Thompson, D. Jayasena, A. Davenport, M. Harrison, and S. P. Newman
Quality of life and emotional responses in cadaver and living related renal transplant recipients
Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2204 - 2211.
[Abstract] [Full Text] [PDF]